Hydroxyapatite Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Hydroxyapatite Market Analysis and Products. The Market is Segmented by Type (Nano-Sized, Micro-Sized, Greater Than Micrometers), Application (Dental Care, Plastic Surgery, Orthopedic, Other Applications), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Sizes and Forecasts are Provided in Terms of Revenue in (USD) for all the Above Segments.

Hydroxyapatite Market Size

Single User License


Team License


Corporate License


Book before:
Hydroxyapatite Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 2.39 Billion
Market Size (2029) USD 3.27 Billion
CAGR (2024 - 2029) 6.44 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Hydroxyapatite Market Major Players

*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License


Book before:

Hydroxyapatite Market Analysis

The Hydroxyapatite Market size is estimated at USD 2.39 billion in 2024, and is expected to reach USD 3.27 billion by 2029, growing at a CAGR of 6.44% during the forecast period (2024-2029).

  • Growing demand for hydroxyapatite for dental implants and increasing demand from the orthopedic segment are expected to drive the market for hydroxyapatite.
  • On the flip side, high expenditure on implants is expected to hinder the growth of the market.
  • The COVID-19 pandemic hampered the hydroxyapatite market as nationwide lockdowns in several countries and strict social distancing measures affected applications such as dental care, plastic surgery, and orthopedics, thereby affecting the market for hydroxyapatite. However, the market registered a significant growth rate after the restrictions were lifted due to the increasing demand for hydroxyapatite from dental care, plastic surgery, and orthopedics applications.
  • The development of 4D and 3D printing technological advancements and the rising interest in prosthetic applications are expected to create more opportunities for the market during the forecast period.
  • North America is expected to dominate the market in the coming years.

Hydroxyapatite Market Trends

Orthopedic Segment to Dominate the Hydroxyapatite Market

  • Hydroxyapatite (HAp) is a fundamental calcium phosphate that exists as the primary material of bones, teeth, and minerals, generally with high bi-affinity. Its composition promotes osseointegration between bone and orthopedic implants, allowing for the ultimate structural and functional connection. Due to its versatility, hydroxyapatite is becoming increasingly popular as an implant coating.
  • As the population ages, orthopedic conditions such as osteoarthritis, osteoporosis, and fractures increase, driving the demand for orthopedic procedures and implants. With the rise in participation in sports and physical activities, there is a corresponding increase in orthopedic injuries requiring surgical intervention.
  • For instance, according to the British Broadcasting Corporation and Premier Injuries, in 2023-24, hamstring injuries were the most common type of injury in the English Premier League, with 53 cases as of November 2023. Meanwhile, knee injuries represented the second-most common injury type, with 28 cases.
  • According to NHS Digital, the number of knee replacement surgeries in the United Kingdom was registered at 74,000 in FY 2022 compared to 31,122 surgeries conducted in the previous year. Thus, the growth of orthopedic surgeries directly impacts the hydroxyapatite market, a key material used in orthopedic implants.
  • According to the WHO, by 2030, one out of every six people will be 60 years old or older. The number of people aged 60 and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of adults aged 60 and up will have doubled (2.1 billion). Between 2020 and 2050, the number of people aged 80 and more is predicted to triple, reaching 426 million.
  • Although the movement in population distribution toward older ages, known as population aging, began in high-income nations (for instance, in Japan, 30% of the population is already over 60 years old), it is currently low and middle-income countries that are seeing the most change. Two-thirds of the world's population over the age of 60 is expected to reside in low and middle-income countries by 2050.
  • With the growing aged population and health issues in several countries worldwide, the demand for orthopedics is expected to increase during the forecast period, thus increasing the demand for hydroxyapatite.
  • All the abovementioned factors are expected to drive the demand for hydroxyapatite during the forecast period.
Hydroxyapatite Market -Number of Knee Replacement Surgeries, United Kingdom, FY 2019 - FY 2022

North America to Dominate the Market

  • North America holds a prominent share of the hydroxyapatite market globally. The region is expected to dominate the hydroxyapatite market during the forecast period due to high investment and better healthcare infrastructure.
  • According to the data published by the US Centers for Medicare & Medicaid Services (CMS), in 2022, US healthcare spending reached USD 4.5 trillion, an increase of 4.1% compared to the previous year. Furthermore, healthcare expenditure reached around USD 4.6 trillion in 2023, and it is estimated to reach around USD 4.9 trillion in 2024.
  • During the period of 2022-2031, the average growth in NHE (national health expenditure) is 5.4% and is projected to outpace the average GDP growth of 4.6%, resulting in an increase in the health spending share of GDP from 18.3% in 2021 to 19.6% in 2031. By 2028, it is anticipated that national health spending will have increased by an average of 5.4%, totaling USD 6.2 trillion.
  • The total population of Canada stood at 38 million in 2023. With the increasing population and rising health awareness among people, the likelihood of health expenditure is increasing. Due to increased consumer knowledge and enhanced information dissemination in the country, the relevance of oral care and oral care products has risen dramatically in recent years. As per the World Health Organization (WHO), around 25% of the adults in Canada are affected by decay and gum diseases.
  • The number of plastic surgeries is increasing in Mexico. As per the report published by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2022, Mexico had around 103,524 breast augmentation, 136,218 liposuction, 71,131 abdominoplasty, 95,521 buttock augmentation, and 81,419 eyelid surgery.
  • As per industry data, healthcare spending in the country reached around USD 112.13 billion in 2023, an increase of 23.8% compared to the previous year. The country’s healthcare spending is anticipated to reach USD 156.51 billion by 2029, which is expected to impact the demand for hydroxyapatite during the forecast period.
  • Thus, the rising demand from various segments is expected to drive the market studied in the region during the forecast period.
Hydroxyapatite Market - Growth Rate by Region

Hydroxyapatite Industry Overview

The hydroxyapatite market is fragmented in nature. Some of the players in the market include (not in any particular order) Zimmer Biomet, HOYA Technosurgical Corporation (HOYA Corporation), Tomita Pharmaceutical Co. Ltd, Merz North America Inc. (Merz Biomaterials), and Sangi Co. Ltd.

Hydroxyapatite Market Leaders

  1. Zimmer Biomet

  2. HOYA Technosurgical Corporation (HOYA Corporation)

  3. Tomita Pharmaceutical Co. Ltd


  5. Merz North America Inc. (Merz Biomaterials)

*Disclaimer: Major Players sorted in no particular order

Hydroxyapatite Market  Concentration
Need More Details on Market Players and Competitors?
Download PDF

Hydroxyapatite Market News

  • March 2022: Zimmer Biomet Holdings Inc. completed its spinoff of ZimVie, Zimmer Biomet's former dental and spine business.
  • March 2022: Cgbio signed a five-year contract worth USD 7.72 Million with Kerunxi Medical, a Chinese company specializing in dental equipment, to export Bongros Dental, a bone graft material.
  • March 2022: CGBio signed an export contract worth USD 77.18 Million with Shanghai Sanyou Medical for its bone substitute "BONGROS" over five years, enhancing its presence in the hydroxyapatite market.

Hydroxyapatite Market Report - Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Drivers

      1. 4.1.1 Growing Demand for Hydroxyapatite for Dental Implants

      2. 4.1.2 Increasing Demand from the Orthopedic Segment

    2. 4.2 Market Restraints

      1. 4.2.1 High Expenditure on Implants

      2. 4.2.2 Other Restraints

    3. 4.3 Industry Value Chain Analysis

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Buyers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size in Value)

    1. 5.1 By Type

      1. 5.1.1 Nano-sized

      2. 5.1.2 Micro-sized

      3. 5.1.3 Greater than Micrometers

    2. 5.2 By Application

      1. 5.2.1 Dental Care

      2. 5.2.2 Plastic Surgery

      3. 5.2.3 Orthopedics

      4. 5.2.4 Other Applications (Including Non-medical Applications)

    3. 5.3 By Geography

      1. 5.3.1 Asia-Pacific

        1. China

        2. India

        3. Japan

        4. South Korea

        5. Rest of Asia-Pacific

      2. 5.3.2 North America

        1. United States

        2. Canada

        3. Mexico

      3. 5.3.3 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Rest of Europe

      4. 5.3.4 South America

        1. Brazil

        2. Argentina

        3. Rest of South America

      5. 5.3.5 Middle East and Africa

        1. Saudi Arabia

        2. South Africa

        3. Rest of Middle East and Africa


    1. 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements

    2. 6.2 Market Ranking Analysis

    3. 6.3 Strategies Adopted by Leading Players

    4. 6.4 Company Profiles

      1. 6.4.1 Berkeley Advanced Biomaterials

      2. 6.4.2 Bio-Rad Laboratories Inc.

      3. 6.4.3 CGbio

      4. 6.4.4 Clarion Pharmaceutical Co.

      5. 6.4.5 Fluidinova

      6. 6.4.6 Hoya Technosurgical Corporation (HOYA Corporation)

      7. 6.4.7 Merz North America Inc. (Merz Biomaterials)

      8. 6.4.8 Reneuco Berhad (Granulab Malaysia SDN. BHD)

      9. 6.4.9 SANGI Co. Ltd

      10. 6.4.10 Sigmagraft Biomaterials

      11. 6.4.11 Taihei Chemical Industrial Co. Ltd

      12. 6.4.12 Tomita Pharmaceutical Co. Ltd

      13. 6.4.13 Zimmer Biomet

    5. *List Not Exhaustive

    1. 7.1 Development of 4D And 3D Printing Technologically Advancement

    2. 7.2 Rising Interest in Prosthetic Applications

**Subject to Availability
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Hydroxyapatite Industry Segmentation

Hydroxyapatite (HAp) is a calcium phosphate similar to the human hard tissues in morphology and composition. It is a bioactive material that will support bone ingrowth and osseointegration. It has been used in orthopedic, dental, and maxillofacial applications and can be replaced with bone formation via osteoconduction.

The hydroxyapatite market is segmented by type, application, and geography. By type, the market is segmented into nano-sized, micro-sized, and greater than micrometers. By application, the market is segmented into dental care, plastic surgery, orthopedics, and other applications (including non-medical applications). The report also covers the market sizes and forecasts for the hydroxyapatite market in 15 countries across the globe. Each segment's market sizing and forecasts are based on value (USD).

By Type
Greater than Micrometers
By Application
Dental Care
Plastic Surgery
Other Applications (Including Non-medical Applications)
By Geography
South Korea
Rest of Asia-Pacific
North America
United States
United Kingdom
Rest of Europe
South America
Rest of South America
Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Hydroxyapatite Market Research FAQs

The Hydroxyapatite Market size is expected to reach USD 2.39 billion in 2024 and grow at a CAGR of 6.44% to reach USD 3.27 billion by 2029.

In 2024, the Hydroxyapatite Market size is expected to reach USD 2.39 billion.

Zimmer Biomet, HOYA Technosurgical Corporation (HOYA Corporation), Tomita Pharmaceutical Co. Ltd, SANGI CO. LTD and Merz North America Inc. (Merz Biomaterials) are the major companies operating in the Hydroxyapatite Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Hydroxyapatite Market.

In 2023, the Hydroxyapatite Market size was estimated at USD 2.24 billion. The report covers the Hydroxyapatite Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Hydroxyapatite Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Hydroxyapatite Industry Report

Statistics for the 2024 Hydroxyapatite market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Hydroxyapatite analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Hydroxyapatite Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)